-
11.发明授权公开(公告)号：US12178566B2
公开(公告)日：2024-12-31
申请号：US17101945
申请日：2020-11-23
Applicant: Medtronic, Inc.
Inventor： David A Anderson , James H Borowick , Hyun J. Yoon , Jon E. Thissen , Shantanu Sarkar , Ashley L Galarneau , Jason C. Lee
Abstract: This disclosure is directed to techniques for detecting and mitigating inaccurate sensing in a medical system. In some examples, one or more sensors of the medical system may include at least one electrode configured to sense an impedance of a portion of a patient's body proximate to the electrode and processing circuitry of the medical system may detect an inaccuracy in the data corresponding to the one or more patient physiological parameters based upon data including at least the sensed impedance of the portion of the patient body; correct at least a portion of the inaccuracy in the data corresponding to the one or more patient physiological parameters; and generate, for display on a display device, output data indicating the inaccuracy in the data corresponding to the one or more patient physiological parameters.
-
12.发明公开公开(公告)号：US20230364435A1
公开(公告)日：2023-11-16
申请号：US18358578
申请日：2023-07-25
Applicant: Medtronic, Inc.
Inventor： Robert M. Ecker , Matthew P. Hanly , Jerry D. Reiland , Hyun J. Yoon , Jon E. Thissen , Gary J. Pauly , Michael B. Terry , Ryan D. Wyszynski , Charles R. Gordon
CPC classification number: A61N1/37276 , A61N1/36592 , A61N1/3655 , A61N1/36521 , A61N1/37223 , A61N1/36585 , H04W76/10 , A61N1/37252
Abstract: Techniques for switching an implantable medical device (IMD) from a first mode to a second mode in relation to signals obtained from internal sensors are described. The internal sensors may include a temperature sensor a biosensor and other sensors. In some examples, processing circuitry of the IMD may make a first preliminary determination that the IMD is implanted based on a first signal from one of the sensors. In response to the first preliminary determination being that the IMD has changed status, the processing circuitry may make a second preliminary determination that the IMD based on a second signal from the biosensor or some other sensor. The processing circuitry may switch the IMD from a first mode to a second mode based on both the first preliminary determination and the second preliminary determination being that the IMD has changed status.
-
公开(公告)号：US20230053188A1
公开(公告)日：2023-02-16
申请号：US17814182
申请日：2022-07-21
Applicant: Medtronic, Inc.
Inventor： Yanina Grinberg , Kathryn E. Hilpisch , Eric R. Williams , Hyun J. Yoon , Todd J. Sheldon
Abstract: A computing device may be communicably coupled to a first pacemaker implanted in a heart of a patient and a second pacemaker implanted in the heart of the patient. The computing device may receive, from the first pacemaker, first race responsive pacing data, and may receive, from the second pacemaker, second rate responsive pacing data. The computing device may synchronize, based at least in part on the first rate responsive pacing data and the second rate responsive pacing data, rate responsive pacing of the first pacemaker and the second pacemaker.
-
公开(公告)号：US11253707B2
公开(公告)日：2022-02-22
申请号：US16600751
申请日：2019-10-14
Applicant: Medtronic, Inc.
Inventor： Hyun J. Yoon , Wade M. Demmer , Matthew J. Hoffman , Robert A. Betzold , Jonathan D. Edmonson , Michael L. Ellingson , Mark K. Erickson , Ben W. Herberg , Juliana E. Pronovici , James D. Reinke , Todd J. Sheldon , Paul R. Solheim
Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
-
公开(公告)号：US20210236828A1
公开(公告)日：2021-08-05
申请号：US17234746
申请日：2021-04-19
Applicant: MEDTRONIC, INC.
Inventor： Hyun J. Yoon , Wade M. Demmer , Matthew J. Hoffman , Robert A. Betzold , Jonathan D. Edmonson , Michael L. Ellingson , Ben W. Herberg , Juliana E. Pronovici , James D. Reinke , Todd J. Sheldon , Paul R. Solheim
Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
-
Patent Agency Ranking
16.发明申请公开(公告)号：US20170312502A1
公开(公告)日：2017-11-02
申请号：US15142814
申请日：2016-04-29
Applicant: MEDTRONIC, INC.
Inventor： Hyun J. Yoon , Michael L. Ellingson , Wade M. Demmer , Jonathan D. Edmonson , Matthew J. Hoffman , Ben W. Herberg , James D. Reinke , Todd J. Sheldon , Paul R. Solheim , Alison M. Seacord
CPC classification number: A61N1/08 , A61N1/3718 , A61N1/3931
Abstract: Implantable medical devices automatically switch from a normal mode of operation to an exposure mode of operation and back to the normal mode of operation. The implantable medical devices may utilize hysteresis timers in order to determine if entry and/or exit criteria for the exposure mode are met. The implantable medical devices may utilize additional considerations for entry to the exposure mode such as a confirmation counter or a moving buffer of sensor values. The implantable medical devices may utilize additional considerations for exiting the exposure mode of operation and returning to the normal mode, such as total time in the exposure mode, patient position, and high voltage source charge time in the case of devices with defibrillation capabilities.
-
公开(公告)号：US12274884B2
公开(公告)日：2025-04-15
申请号：US17955478
申请日：2022-09-28
Applicant: Medtronic, Inc.
Inventor： Michael L. Ellingson , Hyun J. Yoon
Abstract: An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.
-
公开(公告)号：US12167908B2
公开(公告)日：2024-12-17
申请号：US17380705
申请日：2021-07-20
Applicant: Medtronic, Inc.
Inventor： Hyun J. Yoon , Jon E. Thissen , Jerry D. Reiland , Ashley L Galarneau
Abstract: This disclosure is directed to devices, systems, and techniques for dynamically adjusting a bio impedance measurement range. An example device includes a plurality of electrodes. The device also includes sensing circuitry configured to sense a bio impedance and processing circuitry. The processing circuitry is configured to apply an excitation signal to the sensing circuitry and, based on the application of the excitation signal, determine a sensed bio impedance value within a bio impedance measurement range. The processing circuitry is also configured to determine whether the sensed bio impedance value is within a predetermined portion of the bio impedance measurement range for a predetermined period of time and based on the sensed bio impedance value being within the predetermined portion of the bio impedance measurement range for the predetermined period of time, adjust the excitation signal.
-
公开(公告)号：US12088634B2
公开(公告)日：2024-09-10
申请号：US18061855
申请日：2022-12-05
Applicant: Medtronic, Inc.
Inventor： Hyun J. Yoon , Bo Zhang , Robert M. Ecker , Ryan D. Wyszynski , Joseph C. Green , David J. Peichel , Sudar Shields , Nicholas C. Wine , Drew J. Thwaites
CPC classification number: H04L63/205 , H04L9/0631 , H04L63/0442 , H04L63/105 , H04L63/18 , H04W12/04 , H04W52/0229 , A61N1/37252 , H04W12/63
Abstract: This disclosure is directed to devices, systems, and techniques for establishing a secure connection between two or more devices. In some examples, a device is configured for wireless communication. The device comprises signal reception circuitry configured to receive communications transmitted according to at least a first communication protocol, communication circuitry configured for wireless communication according to at least a second communication protocol, and processing circuitry electrically coupled to the signal reception circuitry and the communication circuitry. The processing circuitry is configured to receive, via the signal reception circuitry, a first signal according to the first communication protocol. In response to receiving the first signal, the processing circuitry is further configured to transmit, via the communication circuitry, a second signal according to the second communication protocol and establish a secure link according to the second communication protocol.
-
公开(公告)号：US11724111B2
公开(公告)日：2023-08-15
申请号：US17234746
申请日：2021-04-19
Applicant: MEDTRONIC, INC.
Inventor： Hyun J. Yoon , Wade M. Demmer , Matthew J. Hoffman , Robert A. Betzold , Jonathan D. Edmonson , Michael L. Ellingson , Ben W. Herberg , Juliana E. Pronovici , James D. Reinke , Todd J. Sheldon , Paul R. Solheim
CPC classification number: A61N1/3718 , A61N1/3931 , A61N1/3684 , A61N1/3688 , A61N1/3956
Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
-
-
-
-
-
-
-
-
-
Search Results
38
records
(took 0.017 seconds)
